Document is current
Any future updates will be listed below
-
Authors
Yang, Shaobo https://orcid.org/0009-0006-5257-6775
Sheffer, Michal
Kaplan, Isabel E.
Wang, Zongqi
Tarannum, Mubin
Dinh, Khanhlinh
Abdulhamid, Yasmin
Bobilev, Eden
Shapiro, Roman
Porter, Rebecca
Soiffer, Robert
Ritz, Jerome https://orcid.org/0000-0001-5526-4669
Koreth, John
Wei, Yun
Chen, Peiru
Zhang, Ke
Márquez-Pellegrin, Valeria
Bonanno, Shanna
Joshi, Neel
Guan, Ming
Yang, Mengdi
Li, Deng https://orcid.org/0009-0002-3030-8009
Bellini, Chiara
Liu, Fuguo
Chen, Jianzhu https://orcid.org/0000-0002-5687-6154
Wu, Catherine J.
Barbie, David
Li, Jiahe https://orcid.org/0000-0002-9889-8546
Romee, Rizwan https://orcid.org/0000-0001-9077-4736
- License Information
-
More Information
Article History
Received: 12 March 2024
Accepted: 29 August 2024
First Online: 4 October 2024
Competing interests
: R.R., J.L., S.Y. and M.S. are named inventors on a patent application that describes the surface display of engineered bacteria. R.R. has sponsored research agreements with CRISPR Therapeutics and Skyline Therapeutics and serves on the scientific advisory board of Glycostem Therapeutics. R.R. and J.C. are co-founders of InnDura Therapeutics. J.R. received research funding from Kite/Gilead, Novartis and Oncternal Therapeutics and serves on advisory boards for Akron Biotech, Clade Therapeutics, Garuda Therapeutics, LifeVault Bio, Novartis and Smart Immune. The other authors declare no competing interests.
